company

STAVANGER TERAPIHUS AS

4016 STAVANGER

Return on Equity
−20 %
Current Ratio
3,88
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue4 000
Net Income−5 000
Total Assets33 000
Total Equity25 000
Income (NOK)2022
Revenue4 000
Expenditure11 000
Operating Profit−7 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−7 000
Tax−2 000
Net Income−5 000
Balance (NOK)2022
Total Fixed Assets2 000
Total Current Assets31 000
Total Assets33 000
Total Retained Equity−5 000
Total Equity25 000
Total Long-Term Debt0
Total Current Debt8 000
Total Equity and Debt33 000
Cash flow (NOK)2022
Sales Income4 000
Other Income0
Revenue4 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure11 000
Operating Profit−7 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−5 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets2 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets2 000
Stock0
Total Investments0
Cash, Bank30 000
Total Current Assets31 000
Total Assets33 000
Total Equity25 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt8 000
Total Current Debt8 000
Total Equity and Debt33 000
Financial indicators2022
Return on Equity−20 %
Debt-to-Equity Ratio0
Operating Profit Margin−175 %
Current Ratio3,88
Quick Ratio3,88
Equity Ratio0,76
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English